Sector Watch: Healthcare - May 03 2018
This is an archive page. To See the most recent Healthcare Sectorwatch click here
IBB: $101.28 -1.40 -1.36% | XBI: $85.92 -1.49 -1.7% | Updated May 03, 2018 04:26 PM
| HEALTHCARE STOCKS - TOP GAINERS | ||||
|---|---|---|---|---|
| LENS Presbia $56.4M |
3.43+1.11 219.8 K 37.3x |
48% | ||
| STAA52WH STAAR Surgical $888.2M |
21.15+4.40 4.2 M 34.5x |
26% | ||
| CHRS Coherus BioSciences $900.0M |
14.90+2.20 1.8 M 3.3x |
17% | ||
| CSII Cardiovascular Systems $915.0M |
26.99+3.70 860.4 K 4.9x |
16% | ||
| NVTR52WH Nuvectra $216.9M |
15.03+1.90 672.1 K 5.1x |
14% | ||
| HEALTHCARE STOCKS - TOP LOSERS | ||||
|---|---|---|---|---|
| CHEK Check-Cap $178.4M |
8.81-3.33 612.0 K |
-27% | ||
| AKAO Achaogen $508.9M |
11.06-3.64 6.1 M 4.3x |
-25% | ||
| ANIK52WL Anika Therapeutics $526.0M |
34.80-11.40 841.1 K 7.7x |
-25% | ||
| CAH52WL Cardinal Health $15.8B |
50.80-13.91 15.5 M 5.9x |
-22% | ||
| ESPR Esperion Therapeutics $985.5M |
36.93-8.82 14.8 M 15.1x |
-19% | ||
Not for trading - Data delayed up to 20 minutes from last update time.
Excludes companies with market caps below $50M.
Market Caps next to company names. Trading volumes below stock prices.
NNx - unusual volume NN times the 3-month avg. volume
52WL - 52-week Low in this trading session
52WH - 52-week High in this trading session
Healthcare Stocks Related News
Coherus BioSciences Re-Submits Biologics License Application for CHS-1701 (Pegfilgrastim Biosimilar Candidate) [globenewswire.com]Vizient, Inc. Recognizes 22 Suppliers and Distributors for Service Excellence | Business Wire [businesswire.com]
Important Stock Score Report Updates for Esperion Therapeutics, Integrated Media Technology, [prnewswire.com]
Important Stock Score Report Updates for Esperion Therapeutics, Integrated Media Technology, Mastercard, Molson Coors, and Wayfair [prnewswire.com]
Pacira Pharmaceuticals, Inc. Reports First Quarter 2018 Financial Results [globenewswire.com]
Cardinal Health Reports Third-quarter Results for Fiscal Year 2018 [prnewswire.com]
Stock Review for Biotech?s Investors -- BioTime, Eleven Biotherapeutics, Endocyte, and Esperion [prnewswire.com]
Stock Review for Biotech's Investors -- BioTime, Eleven Biotherapeutics, Endocyte, and Esperion Therapeutics [prnewswire.com]
Achaogen Announces FDA Advisory Committee Voted Unanimously in Favor of Plazomicin for Treatment of Adults with Complicated Urinary Tract Infections [globenewswire.com]
Cardiovascular Systems, Inc. Reports Fiscal 2018 Third-Quarter Financial Results | Business Wire [businesswire.com]
Anika Reports First Quarter 2018 Financial Results | Business Wire [businesswire.com]
STAAR Surgical Reports First Quarter 2018 Results; Revenue Increases 33 Percent on Accelerating EVO Visian ? ICL Momentum | Business Wire [businesswire.com]
Nuvectra? Reports First Quarter 2018 Financial Results [globenewswire.com]
Ohio Bioscience Impacting Lives and Creating Jobs | Business Wire [businesswire.com]
Market Trends Toward New Normal in Cohen & Steers, Achaogen, Ares Commercial Real Estate, CONMED, Marcus, and First Defiance Financial ? Emerging Consolidated Expectations, Analyst Ratings [globenewswire.com]
Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports First Quarter 2018 Financial Results [globenewswire.com]
Achaogen Stock Trading Halted Today [globenewswire.com]
Esperion Announces Positive Top-Line Results from Pivotal Phase 3 Long-Term Safety Study of Bempedoic Acid [globenewswire.com]
Global Medical Equipment Market Report 2018: Market Was Worth $383.9 Billion in 2017 with In-Vitro Diagnostics Accounting for 14.7% of Market Share - ResearchAndMarkets.com | Business Wire [businesswire.com]
Cardinal Health urEssential Award Recognizes Laboratory Professor?s Distinguished Career [prnewswire.com]
Cardinal Health urEssential Award Recognizes Laboratory Professor's Distinguished Career [prnewswire.com]
Coherus BioSciences Management to Present at the Bank of America Merrill Lynch Health Care Conference in Las Vegas, Nevada [globenewswire.com]
Report: Developing Opportunities within AMC Networks, JELD-WEN Holding, Blueprint Medicines, Northwest Bancshares, Anika Therapeutics, and Aethlon Medical ? Future Expectations, Projections Moving into 2018 [globenewswire.com]
Lexington Releases Audited Consolidated Financial Statements [globenewswire.com]
Achaogen Wins CARB-X Funding Award to Advance Development of Novel Aminoglycoside to Fight Highly-Resistant Infections [globenewswire.com]
Managed Care Pharmacy Leaders Are Honored at the Academy of Managed Care Pharmacy/AMCP Foundation Awards Dinner [prnewswire.com]
Diabetic Neuropathy Treatment: World Market 2018-2028 - Visiongain Report [prnewswire.com]
Achaogen to Host Conference Call and Webcast of First Quarter 2018 Financial Results on May 4, 2018 [globenewswire.com]
Anika to Present at the 2018 Deutsche Bank Health Care Conference on May 8, 2018 | Business Wire [businesswire.com]
Coherus BioSciences to Report First Quarter 2018 Financial Results on May 10th [globenewswire.com]
Disclaimer Red Acre Investments is not a registered investment advisor and the views and opinions offered herein do not constitute investment advice. Investors should always conduct their own due diligence before trading. You should assume that Red Acre is trading the securities mentioned in our Red Acre Insights, generally in accordance with the views we express, although our positions may change as news evolves. We do not undertake any obligation to update our views as market conditions evolve.
